Investing.com - Edwards Lifesciences (NYSE:EW) reported fourth quarter earnings that missed analysts' expectations on Wednesday and revenue that fell short of forecasts.
The firm reported earnings per share of $0.51 on revenue of $1.33B. Analysts polled by Investing.com expected EPS of $0.5473 on revenue of $1.36B. .
Edwards Lifesciences shares lost 5.18% to trade at $103.00 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are down 17%, under-performing the Nasdaq which is down 13.44% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On Tuesday, J&J reported fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecasts of EPS of $2.12 on revenue of $25.28B.
UnitedHealth earnings beat analyst's expectations on January 19, with fourth quarter EPS of $4.48 on revenue of $73.74B. Investing.com analysts expected EPS of $4.3 on revenue of $72.98B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar